|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.45 DKK | +1.70% |
|
+4.71% | -2.04% |
| 04-13 | Lundbeck to present new neurology data at upcoming congress | FW |
| 03-23 | H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth | MT |
Company Valuation: H. Lundbeck A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 25,433 | 31,719 | 39,416 | 41,398 | 39,954 | - | - |
| Change | - | 24.72% | 24.27% | 5.03% | -3.49% | - | - |
| Enterprise Value (EV) 1 | 27,464 | 31,008 | 51,598 | 49,619 | 44,170 | 39,874 | 36,004 |
| Change | - | 12.91% | 66.4% | -3.84% | -10.98% | -9.73% | -9.71% |
| P/E ratio | 13.5x | 14.2x | 13x | 13.4x | 9.62x | 9.53x | 10.2x |
| PBR | 1.24x | 1.47x | 1.64x | 1.72x | 1.43x | 1.27x | 1.18x |
| PEG | - | 0.7x | 0.3x | 8.5x | 0.3x | 10.39x | -1.54x |
| Capitalization / Revenue | 1.39x | 1.59x | 1.79x | 1.68x | 1.57x | 1.57x | 1.6x |
| EV / Revenue | 1.51x | 1.56x | 2.34x | 2.01x | 1.74x | 1.56x | 1.44x |
| EV / EBITDA | 5.89x | 5.49x | 8.13x | 6.3x | 5.54x | 4.99x | 4.74x |
| EV / EBIT | 9.63x | 9.71x | 15.8x | 9.41x | 7.3x | 6.61x | 6.38x |
| EV / FCF | 10.2x | 8.66x | 18.7x | 10.2x | 8.33x | 6.81x | 6.64x |
| FCF Yield | 9.83% | 11.5% | 5.35% | 9.8% | 12% | 14.7% | 15.1% |
| Dividend per Share 2 | 0.58 | 0.7 | 0.95 | 1.15 | 1.4 | 1.423 | 1.381 |
| Rate of return | 2.23% | 2.14% | 2.3% | 2.66% | 3.35% | 3.41% | 3.31% |
| EPS 2 | 1.93 | 2.31 | 3.17 | 3.22 | 4.34 | 4.38 | 4.09 |
| Distribution rate | 30.1% | 30.3% | 30% | 35.7% | 32.3% | 32.5% | 33.8% |
| Net sales 1 | 18,246 | 19,912 | 22,004 | 24,630 | 25,374 | 25,516 | 24,943 |
| EBITDA 1 | 4,663 | 5,652 | 6,347 | 7,881 | 7,969 | 7,991 | 7,598 |
| EBIT 1 | 2,852 | 3,195 | 3,270 | 5,275 | 6,047 | 6,031 | 5,643 |
| Net income 1 | 1,916 | 2,290 | 3,143 | 3,192 | 4,365 | 4,596 | 4,217 |
| Net Debt 1 | 2,031 | -711 | 12,182 | 8,221 | 4,215 | -80.41 | -3,950 |
| Reference price 2 | 26.05 | 32.76 | 41.32 | 43.16 | 41.74 | 41.74 | 41.74 |
| Nbr of stocks (in thousands) | 992,840 | 992,840 | 992,011 | 991,227 | 991,227 | - | - |
| Announcement Date | 07/02/23 | 07/02/24 | 05/02/25 | 04/02/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 9.62x | 1.74x | 5.54x | 3.35% | 6.3B | ||
| 24.64x | 0.26x | 15.97x | 0.35% | 106B | ||
| 25.94x | 0.21x | 14.06x | 0.96% | 50.15B | ||
| 43.76x | 2.95x | 27.44x | 1.45% | 22.59B | ||
| 16.05x | 1.3x | 10.12x | 1.94% | 9.05B | ||
| 11.69x | 0.22x | 5.76x | 2.5% | 8.39B | ||
| 7.66x | 0.1x | 2.89x | 3.93% | 8.27B | ||
| 24.84x | 1.23x | 15.33x | 2.82% | 5.72B | ||
| 10.12x | 0.14x | 4.81x | 4.18% | 3.9B | ||
| 13.66x | - | - | 2.26% | 3.64B | ||
| Average | 18.80x | 0.91x | 11.32x | 2.38% | 22.42B | |
| Weighted average by Cap. | 24.55x | 0.63x | 15.08x | 1.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HLUN B Stock
- Valuation H. Lundbeck A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















